Paving the Way for Diverse & Equitable Next Generation
Precision Medicine Clinical Trials
Establishing Collaborative Strategies to Improve Recruitment of Historically Marginalized Communities in Clinical Trials to Ensure Future Precision Medicines Are Fit For All
When: September 27, 8.00am – 5.00pm
Where: Boston - The Westin Boston Seaport District
Note: This meeting is taking place in-person only and online attendance will not be available
Under-represented racial and ethnic populations have a long history of being mistreated by the health care system, researchers and the government. While the goal of precision medicine is to help everybody, the current research is largely based on the genes of people who are predominantly of white and European descent. As an industry, it is our responsibility to leverage our position to influence and drive action towards greater clinical trial diversity, equity and inclusion for all communities around the world.
That is why, the 4th Equity, Diversity & Inclusion in Precision Medicine Summit is returning to Boston to tackle the key barriers and challenges to clinical trial participation and discuss how to better align precision medicine trial participants with consumer populations.
You can expect case studies, presentations, panel discussions, roundtable discussions and networking opportunities to facilitate the development of better treatments and better ways to fight diseases that often disproportionately impact diverse communities.
Do not miss out on this opportunity and join 80+ thought leaders in Boston to pave the way for the future of precision medicine clinical trials!
2022 Expert Speaker Faculty:
Proud to Partner With:
Note: This meeting is taking place in-person only and online attendance will not be available. Registration to the summit is free, but the event is operating with limited capacity.
What Will We Cover?
Please note: This meeting is taking place in-person only and online attendance will not be available.
This is the key in-person meeting for any precision medicine expert looking to draw from the experience of leading pharma and biotechs to help establish clear guidelines, expertise and processes to improve diversity in precision medicine clinical trials and therefore, enhance drug safety, improve drug development, and support fair access to medicines for all patients.
Address financial, geographical and trust burdens to clinical trial participation and how precision medicine is aiming to mitigate them
Tap into real-world examples that enabled more inclusivity in trial, as well as tailored strategies to engage with different communities
Discuss best practices and opportunities to address diversity and inclusion in DCTs and maximize clinical enrollment
Identify strategies to improve genomic representation and have a better understanding of the disease
Explore how to overcome unconscious bias in clinical healthcare to build a fairer future for patients
What’s New in 2022?
From discussing practical steps to increase representation of historically marginalized communities in trials to highlighting how Decentralized Clinical Trials (DCTs) could help diversify the patient population, you can expect:
Addressing Barriers to Increase Diversity in Precision Medicine Clinical Trials
Translating Diversity in Leadership into Diversity in Clinical Enrollment
Widening Your Global Patient Outreach with DCTs
Building Inclusivity into Preclinical Precision Medicine Study Designs
Discussing How to Overcome Unconscious Bias in Clinical Healthcare to Build a Fairer Future for Patients
Note: This meeting is taking place in-person only and online attendance will not be available. Registration to the summit is free, but the event is operating with limited capacity.
VENUE & AGENDA
The World Clinical Biomarkers & CDx Summit and the Equity, Diversity & Inclusion in Precision Medicine Day will be held at:
The Westin Boston Seaport District
425 Summer St, Boston, MA, 02210
Proud to Partner With: